AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 82 min read$TLRY

Tilray revenue rises as beverage business drives record quarterly sales

Tilray Inc reported Q1 revenue of $257.1M, up 23% YoY, driven by beverage growth. Gross profit rose 35% to $77.5M. Beverage revenue increased 82% to $101.5M, while cannabis revenue fell. Net loss was $40M, with adjusted EBITDA at $9.2M. The company reaffirmed its fiscal 2027 adjusted EBITDA forecast of $68M-$75M.

Original reporting
finance.yahoo.com
Published Oct 8, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 3:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Tilray revenue rises as beverage business drives record quarterly sales — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$TLRYBearishMed
01

Why it matters

The earnings release shows top‑line growth but bottom‑line weakness, prompting a modest share decline.

02

Market read

First‑quarter earnings provide fresh data for traders; the mixed results suggest short‑term downside with potential upside from beverage growth.

03

What to watch

BrewDog acquisition synergies and strong beverage margins may materialize later in the year.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Tilray is a NASDAQ‑listed cannabis and consumer products company that recently acquired BrewDog to expand its beverage portfolio.

Company-level read

Ticker impact

$TLRYBearishHigh confidence
Context

Tilray reported record Q1 revenue of $257.1M, 23% YoY growth, but net loss of $40M and shares fell ~3% pre‑market.

Expected impact

likely further pressure as market prices in the net loss and weaker EBITDA guidance.

Evidence & confidence

Revenue beat is offset by a larger net loss and a modest guidance reaffirmation, causing the stock to trade down.

Market effects

Sector

Cannabis sector may see broader scrutiny as earnings highlight margin pressure despite revenue growth.

Regional

International expansion in EMEA shows growth but may not offset US market weakness.

Global

Limited; primarily affects Tilray and peers in the cannabis space.

Counterpoint

What could challenge this read

Revenue surge and beverage segment strength could support a rebound if cost controls improve.

Key entities

  • company
    Tilray Inc

    NASDAQ: TLRY, cannabis and consumer products firm.

Read at source← All news

Also covered by

4 outlets

Related articles

OCT 8
$TLRYMed

Tilray Brands (TLRY) Shares Slip Premarket After Q1 Revenue Miss

Tilray Brands (TLRY) reported Q1 revenue of $257.2M, up 23% YoY but below estimates by $9.7M. Cannabis revenue declined 13%, while beverage and distribution segments grew. The company posted a net loss of $3.0M but beat adjusted EPS estimates by $0.16. Tilray's P/S ratio is 0.45, below historical and industry averages, reflecting market skepticism about future growth.

gurufocus.com3 min
OCT 8
$TLRYMed

Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit…

Tilray Brands, Inc. (TLRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution First-Quarter Results

SEC EDGAR 8-K2 min
AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min